EE265 Cost-Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients With Treatment Failure After C5 Inhibitor Therapy: An Analysis From the Brazilian Public Healthcare System Perspective
Abstract
Authors
Mauricio Penaquio Nilson Carvalho Valnei Canutti Gabriel Leonel Marasco Camila Pepe Fernanda Bertasi